Trial intelligence / Profile preview

Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers

NCT02596360Phase 1Completed

Sponsor
Centre Hospitalier Universitaire de Clermont-Ferrand
Start
Nov 2015
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in hyperalgesia and pain comparing Dextromethorphan with Placebo (2 arms). Primary endpoint: Area under the curve of percentage changes in mechanical pain thresholds in secondary hyperalgesic zone. Started Nov 2015; status: completed.

02

Drugs

dextromethorphan
03

Conditions

hyperalgesiapain

Beyond the preview

Go deeper on NCT02596360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02596360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call